Stockholders' Equity | Stockholders' Equity Stockholders' Equity Rollforward The following tables provide a rollforward of our stockholders' equity for the three months ended June 30, 2022 and 2021 (in thousands, except share and per share data): AOCI (Loss) Retained Equinix Non-controlling Interests Total Stockholders' Equity Common Stock Treasury Stock Additional Accumulated Shares Amount Shares Amount Balance as of December 31, 2021 90,872,826 $ 91 (301,420) $ (112,208) $ 15,984,597 $ (6,165,140) $ (1,085,751) $ 2,260,493 $ 10,882,082 $ (318) $ 10,881,764 Net income — — — — — — — 147,453 147,453 240 147,693 Other comprehensive income — — — — — — 32,837 — 32,837 3 32,840 Issuance of common stock and release of treasury stock for employee equity awards 430,973 — 11,445 4,259 39,617 — — — 43,876 — 43,876 Dividend distribution on common stock, $3.10 per share — — — — — (282,031) — — (282,031) — (282,031) Settlement of accrued dividends on vested equity awards — — — — — (497) — — (497) — (497) Accrued dividends on unvested equity awards — — — — — (2,045) — — (2,045) — (2,045) Stock-based compensation, net of estimated forfeitures — — — — 121,210 — — — 121,210 — 121,210 Balance as of March 31, 2022 91,303,799 91 (289,975) (107,949) 16,145,424 (6,449,713) (1,052,914) 2,407,946 10,942,885 (75) 10,942,810 Net income (loss) — — — — — — — 216,322 216,322 (80) 216,242 Other comprehensive loss — — — — — — (365,842) — (365,842) (35) (365,877) Issuance of common stock and release of treasury stock 36,682 — 24,609 9,157 4,882 — — — 14,039 — 14,039 Dividend distribution on common stock, $3.10 per share — — — — — (282,168) — — (282,168) — (282,168) Settlement of accrued dividends on vested equity awards — — — — — (57) — — (57) — (57) Accrued dividends on unvested equity awards — — — — — (4,400) — — (4,400) — (4,400) Stock-based compensation, net of estimated forfeitures — — — — 109,005 — — — 109,005 — 109,005 Balance as of June 30, 2022 91,340,481 $ 91 (265,366) $ (98,792) $ 16,259,311 $ (6,736,338) $ (1,418,756) $ 2,624,268 $ 10,629,784 $ (190) $ 10,629,594 Additional Accumulated AOCI (Loss) Retained Equinix Non-controlling interests Total Stockholders' Equity Common Stock Treasury Stock Shares Amount Shares Amount Balance as of December 31, 2020 89,462,304 $ 89 (328,052) $ (122,118) $ 15,028,357 $ (5,119,274) $ (913,368) $ 1,760,302 $ 10,633,988 $ 130 $ 10,634,118 Net income (loss) — — — — — — — 156,362 156,362 (288) 156,074 Other comprehensive loss — — — — — — (95,480) — (95,480) (1) (95,481) Issuance of common stock and release of treasury stock for employee equity awards 428,618 1 11,640 4,332 35,701 — — — 40,034 — 40,034 Dividend distribution on common stock, $2.87 per share — — — — — (256,321) — — (256,321) — (256,321) Settlement of accrued dividends on vested equity awards — — — — — (437) — — (437) — (437) Accrued dividends on unvested equity awards — — — — — (3,661) — — (3,661) — (3,661) Stock-based compensation, net of estimated forfeitures — — — — 102,349 — — — 102,349 — 102,349 Balance as of March 31, 2021 89,890,922 90 (316,412) (117,786) 15,166,407 (5,379,693) (1,008,848) 1,916,664 10,576,834 (159) 10,576,675 Net income — — — — — — — 68,339 68,339 148 68,487 Other comprehensive income — — — — — — 67,734 — 67,734 11 67,745 Issuance of common stock and release of treasury stock for employee equity awards 36,674 — 1,389 516 (516) — — — — — — Issuance of common stock under ATM Program 137,604 — — — 99,599 — — — 99,599 — 99,599 Dividend distribution on common stock, $2.87 per share — — — — — (257,199) — — (257,199) — (257,199) Settlement of accrued dividends on vested equity awards — — — — — (55) — — (55) — (55) Accrued dividends on unvested equity awards — — — — — (4,016) — — (4,016) — (4,016) Stock-based compensation, net of estimated forfeitures — — — — 95,236 — — — 95,236 — 95,236 Balance as of June 30, 2021 90,065,200 $ 90 (315,023) $ (117,270) $ 15,360,726 $ (5,640,963) $ (941,114) $ 1,985,003 $ 10,646,472 $ — $ 10,646,472 Accumulated Other Comprehensive Loss The changes in accumulated other comprehensive loss, net of tax, by components are as follows (in thousands): Balance as of December 31, Net Balance as of June 30, Foreign currency translation adjustment ("CTA") loss $ (1,068,399) $ (862,930) $ (1,931,329) Unrealized gain (loss) on cash flow hedges (1) (6,590) 84,654 78,064 Net investment hedge CTA gain (loss) (1) (9,952) 445,311 435,359 Net actuarial loss on defined benefit plans (2) (810) (40) (850) Accumulated other comprehensive loss attributable to Equinix $ (1,085,751) $ (333,005) $ (1,418,756) (1) Refer to Note 7 for a discussion of the amounts reclassified from accumulated other comprehensive loss to net income. (2) We have two defined benefit pension plans covering all employees in two countries where such plan is mandated by law. Changes in foreign currencies can have a significant impact to our condensed consolidated balance sheets (as evidenced above in our foreign currency translation loss), as well as our condensed consolidated results of operations, as amounts in foreign currencies are generally translated into more U.S. Dollars when the U.S. Dollar weakens or fewer U.S. Dollars when the U.S. Dollar strengthens. As of June 30, 2022, the U.S. Dollar was generally stronger relative to certain of the currencies of the foreign countries in which we operate as compared to December 31, 2021. Because of this, the U.S. Dollar had an overall unfavorable impact on our condensed consolidated financial position because the foreign denominations translated into fewer U.S. Dollars as evidenced by an increase in foreign currency translation loss for the six months ended June 30, 2022 as reflected in the condensed consolidated statements of comprehensive income (loss). The volatility of the U.S. Dollar as compared to the other currencies in which we operate could have a significant impact on our condensed consolidated financial position and results of operations including the amount of revenue that we report in future periods. Common Stock In October 2020, we established an ATM program, under which we may, from time to time, offer and sell our common stock to or through sales agents in "at the market" transactions (the "2020 ATM Program"). In February 2022, we entered into a forward sale amendment to the 2020 ATM Program, under which we may, from time to time, offer and sell shares under the equity distribution agreement pursuant to forward sale transactions (the "Equity Forward Amendment"). Under the 2020 ATM Program and Equity Forward Amendment we may, from time to time, offer and sell our common stock to or through sales agents up to an aggregate amount of $1.5 billion. The forward sale agreements provide three settlement alternatives to us: physical settlement, cash settlement or net share settlement. In accordance with ASC 815, the forward sale agreements are classified as equity for balance sheet purposes. As of June 30, 2022, we executed five forward sale agreements to sell 579,873 shares of our common stock with maturity dates ranging from March 2023 to June 2023. The future gross settlement value for the forward sale agreements is approximately $394.8 million at an aggregate weighted-average forward sale price of $680.77 per share. The weighted-average forward sale price that we expect to receive upon physical settlement will be subject to adjustments for a discount rate factor equal to a specified benchmark rate less a spread minus scheduled dividends during the terms of the agreements. As of June 30, 2022, we had $605.2 million of common stock remaining available for sale under the 2020 ATM Program, which amount gives effect to the unsettled forward sale transactions noted above. For the three and six months ended June 30, 2022 no shares were issued under the 2020 ATM Program. For the three and six months ended June 30, 2021, we issued 137,604 shares under the 2020 ATM Program, for approximately $99.6 million, net of payment of commissions to sales agents and other offering expenses. Stock-Based Compensation For the six months ended June 30, 2022, the Compensation Committee and/or the Stock Award Committee of our Board of Directors, as the case may be, granted an aggregate of 794,013 restricted stock units ("RSUs") to certain employees, including executive officers. These equity awards are subject to vesting provisions and have a weighted-average grant date fair value of $663.94 per share and a weighted-average requisite service period of 3.51 years. The valuation of RSUs with only a service condition or a service and performance condition require no significant assumptions as the fair value for these types of equity awards is based solely on the fair value of our stock price on the date of grant. We use revenues, adjusted funds from operations ("AFFO") per share and digital services revenues as the performance measurements in the RSUs with both service and performance conditions that were granted in the six months ended June 30, 2022. We use a Monte Carlo simulation option-pricing model to determine the fair value of RSUs with a service and market condition. We used total shareholder return ("TSR") as the performance measurement in the RSUs with a service and market condition that were granted in the six months ended June 30, 2022. There were no significant changes in the assumptions used to determine the fair value of RSUs with a service and market condition that were granted in 2022 compared to the prior year. The following table presents, by operating expense category, our stock-based compensation expense recognized in our condensed consolidated statements of operations (in thousands): Three Months Ended Six Months Ended 2022 2021 2022 2021 Cost of revenues $ 11,878 $ 10,008 $ 22,321 $ 18,475 Sales and marketing 23,171 20,779 43,355 38,482 General and administrative 69,633 63,548 128,958 115,728 Total $ 104,682 $ 94,335 $ 194,634 $ 172,685 |